Unimarck Pharma (India) Limited, a active public limited company, was established on 12 March 1984 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH1984PLC005768. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.79 Cr.
Formerly known as Unimarck Pharma Private Limited. It upholds a compliant status. Employing 409 professional, Its leadership includes Gagandeep Bhatia (Whole-Time Director), Harleen Kaur Bhatia (Director), Harsh Bhatia (Whole-Time Director). Past directors included Gagandeep Bhatia, Judgebir Singh Ahluwalia, Sukhbir Singh Nayar. It holds ₹21.65 Cr open charges and ₹37.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 56 & 57, Next To Gpo, Shopping Plaza 17D, Sector 17, Chandigarh, Chandigarh, 160017.
U24232CH1984PLC005768
005768
12 March 1984
₹2.00 Cr
₹1.79 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Unimarck Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gagandeep Bhatia | Whole-Time Director | 10 Aug 2000 | Current |
| Harleen Kaur Bhatia | Director | 01 Apr 2023 | Current |
| Harsh Bhatia | Whole-Time Director | 12 Mar 1984 | Current |
| Mandeep Singh | Managing Director | 03 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2007 | Past |
| Pramod Abcsdd | Director | 06 Jul 2009 | Past |
| Pramod Abcsdd | Director | 06 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unimarck Pharma (India) Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 16.96% decrease. The company also saw a substantial fall in profitability, with a 30.12% decrease in profit. The company's net worth dipped by a decrease of 8.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Unimarck Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹216,540,000.00
₹369,954,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2023 | Others | ₹1.59 M | Open |
| 10 May 2017 | Others | ₹13.26 Cr | Open |
| 17 Jul 1993 | Others | ₹8.24 Cr | Open |
| 10 Sep 2021 | Hdfc Bank Limited | ₹8.50 M | Satisfied |
| 17 Apr 2015 | Punjab National Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unimarck Pharma (India) has a workforce of 409 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Unimarck Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimarck Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 10 Sep 2021 via Charge ID 100485631 with Hdfc Bank Limited was fully satisfied on 08 Dec 2024. was completed.
The activity Unimarck Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Unimarck Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.16 Cr with Charge ID 100741152 was registered on 01 Jul 2023. was documented.
Harleen Kaur Bhatia was appointed as a Director was appointed as a Director on 01 Apr 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.
A charge with Others of Rs. 13.26 Cr registered on 10 May 2017 with Charge ID 100099413 was modified on 19 May 2022. was recorded as a recent event.
The CIN of Unimarck Pharma (India) Limited is U24232CH1984PLC005768.
Unimarck Pharma (India) Limited is headquartered at Sco 56 & 57, Next To Gpo, Shopping Plaza 17D, Sector 17, Chandigarh, Chandigarh, 160017.
Unimarck Pharma (India) Limited was incorporated on 12 March 1984.
The current directors of Unimarck Pharma (India) Limited are
The primary industry of Unimarck Pharma (India) Limited is Manufacturing.
Unimarck Pharma (India) Limited is unlisted.
The authorized capital of Unimarck Pharma (India) Limited is ₹2.00 Cr, and the paid-up capital is ₹1.79 Cr.
The compliance status of Unimarck Pharma (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX